Long Island’s revered Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, and biology. Now, CSHL is focusing its research and education expertise to help combat COVID-19.

Join us to hear from Dr. Bruce Stillman, President and CEO at CSHL, about these extraordinary efforts going on in our own backyard. Learn about how CSHL research facilities have been repurposed to produce critical coronavirus proteins to help test patients for antibodies and develop therapies and preventative treatments. He will also discuss the development of a method to treat the most advanced COVID-19 patients that is now in clinical trials and the development of a new clinical trial with a drug that has the potential to limit COVID-19 symptoms. 

As always, Joe and Peter will also discuss the latest business recovery and market updates.

DATE: Tuesday, September 1

TIME: 11:30 A.M.